10/21/2013 10:05:54 AM
On August 30th, 2013, Meda (STO:MEDAA) announced the acquisition of Acton Pharmaceuticals, Inc. and its proprietary product Aerospan. The acquisition has now been completed. The purchase price for Acton amounted to 135 MUSD, on a cash and debt free basis. In addition, there is a milestone payment of 10 million USD and royalty based milestones.
Help employers find you! Check out all the jobs and post your resume.
comments powered by